Biomoneta creates solutions to prevent the spread of infections in hospitals & and other healthcare facilities and to preclude product contamination in critical pharmaceutical & biotechnology environments.
Our products enable a substantial reduction in risk to lives and businesses threatened by microbial contamination, including multi-drug resistant organisms. Biomoneta is led by a multi-disciplinary team with decades of experience in infection biology, product engineering and sales.
Biomoneta’s flagship product is an advanced air decontamination technology, ZeBox, that can be used in human presence with zero downtime and low lifetime maintenance.
It is the only Indian product that is certified for killing a wide spectrum of airborne pathogens by a nationally accredited lab that does airborne-microbe testing. In a Department of Biotechnology, Govt of India funded study, the Indian Institute of Science showed the technology is effective on the airborne Covid-19 virus with over 10 million virus particles destroyed in 5 minutes.
This real-world-proven hospital-grade technology is used in ICUs, Procedure Rooms, NICUs & Ambulances to improve patient safety and reduce risk to doctors and healthcare workers.
The ZeBox is also used in Change Rooms, Tissue-Culture Labs & Biomedical Research Facilities to ensure bioburden control, which prevents bio-product contamination and production loss.
Biomoneta is privileged to be recognized by multiple awards.
We have received grant awards from the Governments of India and Karnataka. We have been recognized by industry bodies such as the Confederation of Indian Industry and the Association of Biotechnology Led Enterprises and picked as one of India’s top startups by the FICCI/PwC LevelNxt program and the FICCI/LockheedMartin/Tata Trust program IIGP2.0.
Grants + Funding